This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Recommendations from the “2014 AHA/ACC/HRS Guideline for the Management of Patients With AtrialFibrillation” and the “2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With AtrialFibrillation” have been updated with new evidence to guide clinicians.
Background Heart failure (HF) is not included in atrialfibrillation (AF) bleeding risk prediction scores, reflecting uncertainty regarding its importance as a risk factor for major haemorrhage. from 2014 onwards), although 75.7% Results Over 7.56 Less than half those with AF were prescribed an anticoagulant (45.6%
Affecting 60 million people worldwide 1 , the prevalence of atrialfibrillation (AFib) is expected to increase by 60% by 2050 due to an aging population and rising cardiometabolic risk factors 2. In addition, the Centers for Disease Control and Prevention (CDC) estimates that more than 12 million Americans will have AFib by 2030 3.
in 2014 and is available worldwide. Results will be presented at the American Heart Association/American Stroke Association ( AHA / ASA ) International Stroke Conference ( ISC ) 2024 in Phoenix. ii] The cost-effectiveness analysis reflects data from 492 patients in the STROKE AF study, which was conducted across 33 centers in the U.S.
“Therefore, we have made the decision to offer only DX technology for new patients needing a single-chamber ICD, providing equivalent therapies along with additional atrial monitoring data, as recommended by current guidelines.” For more information: [link] References: Thomas G, Choi DY, Doppalapudi H, et al. Technol Health Care.
a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrialfibrillation ( AF ) using pulsed field ablation (PFA). AtrialFibrillation. Circulation.
Methods Patients with a first episode of acute pericarditis were consecutively enrolled between January 2014 and June 2022, and divided into four groups according to age (G1: 18–35 years; G2: 35–55 years; G3: 55–75 years; G4: >75 years). A secondary cause of pericarditis was detected in 128/471 (27.2%) patients.
Methods This was a retrospective study of all patients who underwent TAVR between 1 January 2014 and 31 December 2017. years and were more likely to be males (62%), diabetic (41% vs 35%, p=0.046), and have a higher prevalence of atrialfibrillation (Afib) (53% vs 39%, p<0.001). Patients with elevated FP had a mean age of 81.2±8.6
Aims Direct-acting oral anticoagulants (DOACs) have, to a substantial degree, replaced vitamin K antagonists (VKA) as treatments for stroke prevention in atrialfibrillation (AF) patients. Methods The target trial approach was applied to the prospective observational Swiss-AF cohort, which enrolled 2415 AF patients from 2014 to 2017.
Introduction:Catheter ablation (CA) is superior to medical therapy in the management of atrialfibrillation (AF). Stroke, Volume 56, Issue Suppl_1 , Page ATP283-ATP283, February 1, 2025. Current guidelines do not take into consideration the history of CA or its outcome when recommending chronic oral anticoagulation (OAC).
This study aimed to identify potentially modifiable factors for better stroke treatment and prevention in minority populations.Methods:We retrospectively identified young patients (aged 18-55 years) who were admitted with ischemic stroke from 01/2014 to 12/2022.
We present our institutional experience with EVT in this patient population.Methods:Prospectively maintained database from our comprehensive stroke center was retrospectively reviewed for consecutive cases from December 2014 to July 2023. Patients who underwent EVT were included.
Echocardiographic assessment of left ventricular diastolic function with special reference on diastolic function assessment in atrialfibrillation. In atrialfibrillation, the absence of atrial contraction and the A wave makes this assessment impossible. 2014 May-Jun;66(3):392-3. Circulation. Kumar V et al.
Case submitted and written by Mazen El-Baba MD, with edits from Jesse McLaren and edits/comments by Smith and Grauer A 90-year old with a past medical history of atrialfibrillation, type-2 diabetes, hypertension, dyslipidemia, presented with acute onset chest/epigastric pain, nausea, and vomiting.
The American College of Cardiology (ACC) and the American Heart Association (AHA) recently published new guidelines for the diagnosis and management of patients with atrialfibrillation (AF). link] ACC/AHA Release Updated AtrialFibrillation Guidelines for 2023. Sources: Joglar, J, Chung, M. J Am Coll Cardiol.
Smith comment: In a large randomized trial of dopamine vs. norepinephrine (11) for shock which was published after the above-mentioned recommendations, dopamine had more adverse events (especially severe dysrhythmias, and especially atrialfibrillation). 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease.
Atrialfibrillation is the most common heart rhythm disorder in adults, affecting more than 5 million people in the U.S., The 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of AtrialFibrillation noted that abstaining from caffeine to prevent heart rhythm disturbances is of no benefit to people with AFib.
Background Individual variation in the need for healthcare constitutes knowledge gaps for young atrialfibrillation (AF) patients. We aimed to estimate the prevalence and primary care burden of early-onset AF in Norway, emphasising sex differences, in a nationwide healthcare database.
We aimed to assess the relationship between daily mean temperature and common pollutants with atrialfibrillation (AF) presentations to emergency departments (EDs).
Background:Catheter ablation (CA) is increasingly used for treatment of atrialfibrillation (AF). However, CA has not been widely adopted in the older population with AF.
Risk factors associated with an increased recurrent stroke rate included impaired BOLD-CVR, a history of atrialfibrillation, and heart insufficiency. After adjusting for sex, age group, and atrialfibrillation, impaired BOLD-CVR exhibited a hazard ratio of 10.73 (95% CI, 4.14–27.81;P<0.001)
Background:Among patients hospitalized for atrialfibrillation (AF), the frequency of off-label direct oral anticoagulant (DOAC) dosing, associated factors, hospital-level variation, and temporal trends in contemporary practice are unknown.Methods:Using the Get With The Guidelines® AtrialFibrillation (GWTG-AF) registry, patients admitted from January (..)
Methods:We used clinical and proteomics data of stroke patients aged 18 years lodged within a prospective plasma repository from 2010 to 2014. We collected blood from each patient at hospital admission before administering any therapeutic intervention.
The observation period was divided into 4 epochs: 2008 to 2010, 2011 to 2013, 2014 to 2016, and 2017 to 2019. 47.0%), direct oral anticoagulants for atrialfibrillation (0.0%–56.2%), Secular trends for patient characteristics, treatments, and outcomes were analyzed.RESULTS:A total of 7050 eligible patients (mean age, 43.1;
Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The Society (..)
Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)
Women were older (77 versus 69 years), had higher rates of atrialfibrillation, hypertension, and greater prestroke disability, but there was no difference in baseline National Institutes of Health Stroke Scale score. The primary outcome was the 90-day ordinal modified Rankin Scale score. 1.21]), FI or RoR (odds ratio, 0.98 [95% CI, 0.78–1.22]),
This study aimed to explore the relationship between the serum prealbumin level and early complications following off-pump coronary artery bypass grafting, in addition to its predictive value.MethodsData were retrospectively collected on patients undergoing off-pump coronary artery bypass grafting from January 2014 to July 2019.
2:34 PM, following right heart catheterization She then went into atrialfibrillation with complete heart block and junctional escape rhythm prompting placement of transvenous pacemaker. The catheter was out of the body and the arteriotomy had been closed, so there is no pressure waveform. Case discussion: This is a tragic case.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
76 
Let's personalize your content